Diabetes Self-Management Blog

At this time in the United States, injection and infusion are the only methods available for taking insulin — but with various teams of researchers hard at work, and with noninjection forms of insulin already making their debut in certain countries, this situation may change in the future.

One product that is already available in Ecuador, India, and, on a very limited basis, Canada, is Oral-lyn, a formulation of Regular insulin that is sprayed into the mouth using a device similar to an asthma inhaler. The insulin is then absorbed through the mucous membranes lining the mouth. Oral-lyn begins lowering blood glucose levels in 5 minutes, peaks at 30 minutes, and stops working at 2 hours. Unlike inhaled insulins (such as the now-discontinued Exubera), Oral-lyn does not enter the lungs, both because of the design of the device used to take it, and because users are instructed not to inhale as they spray. Oral-lyn is currently in Phase III trials (trials to definitively assess the drug’s effectiveness) in the United States, Canada, Russia, Ukraine, Bulgaria, Romania, and Poland. It is being developed by Generex Biotechnology Corporation and is intended for use in people with Type 1 or Type 2 diabetes.

Oramed Pharmaceuticals, Inc., a company that creates oral methods for administering drugs typically given by injection, is also developing a noninjectable insulin. Presently in clinical trials to assess safety and effectiveness, this drug is a form of Regular insulin that is delivered in capsules that are swallowed. It will initially be intended for use in people with Type 2 diabetes. The capsules are specially formulated to avoid breakdown while in transit through the stomach. The insulin is absorbed in the intestine and then travels first to the liver.

According to the company, routing insulin to the liver first more closely mimics what normally happens in a person without diabetes than injecting or infusing insulin under the skin. The insulin signals the liver to store glucose and to refrain from releasing stored glucose to the bloodstream. This helps to lower the blood glucose level, relieving some of the burden on the pancreas to produce insulin, and therefore helping to preserve pancreatic function for longer.

Oramed Pharmaceuticals plans for the capsules to be available in select countries within the next few years and anticipates approval in the United States to follow several years later.

A set of researchers funded by the Indian government is also in the process of developing an insulin pill, which is scheduled to be studied in human trials within several months. This pill makes use of nanoparticles (extremely small particles) to deliver insulin to the bloodstream. Additional methods of insulin delivery now in the early stages of development are sublingual insulin, or insulin that is placed and absorbed under the tongue; inhalable insulin that is delivered through the lungs; and insulin suppositories to be absorbed through the lining of the rectum.

This blog entry was written by Diane Fennell, Associate Editor of Diabetes Self-Management magazine.


  1. Dear Web Team.

    I like the idea of oral-lyn short duration action could be great for correcting post meal highs. The inhaled one was a bust a lady said she had poor control on it. The beauty of injecting insulin is that the phenomenon is fairly reproducible remains to be seen if other techniques can match this.

    Posted by CalgaryDiabetic |
  2. This is exciting news!!! Keep us updated on the progress of the drug…

    Posted by Lynn in Greensboro NC |
  3. Post meal has always been a problem for me. This would be a big help. When will this spray be available to the public?

    Posted by Tom |
  4. My cousin lives in India and has been using it for two weeks now and has her blood sugars in good control. She will never go back to injections.

    Posted by ccrn123 |
  5. This is wonderful news. This is such a break through for insulin users. Why can’t the FDA speed up approval? Is there any way to get it from India? I am just starting insulin and would love to get my hands on any of these products.

    Posted by Fred |
  6. Hi Fred,

    The question of whether the FDA is too cautious or too lenient is the source of some debate. You may want to check out our recent Diabetes Flashpoints post, “FDA: Stifler or Savior?” for details about the FDA’s recent tightening of standards for new diabetes drugs and the reactions of people in the diabetes community.

    Posted by Tara Dairman, Web Editor |
  7. I am having tablets 3 times daily to control my diebetes;so I,m verymuch interested to know that
    I’ll get Oral Insulin in the near future in India also at afordable rates,if so ;it’ll be a good relief to me as I can avoid the risk of the side-effects of consuming so many tablets ,sice I’m,taking other tabs for controlling my hypertension,cholestrol etc also.

    Posted by Ariyannur Sambhu Nampoothiri.Fort,TVM. |

    Posted by TOM ADAMS |
  9. Awesome, the sooner the better.

    Posted by Dwight |
  10. Very recently I was watching a documentary series that followed women (in the US) through their pregnancy and delivery experiences. One of the women had developed gestational diabetes and she was put on insulin tablets. The show then filmed her dispensing and taking two small pills. This was the first I had heard about oral insulin so I looked it up online. I am curious how she was able to get the medication, as everything I’ve read on it so far seems to indicate that it is not yet available. Any ideas how she might have gotten it?

    Posted by M. Dodge |
  11. thanks a lot.Keep us updated please

    Posted by foolad eghbali |
  12. i would be intersted in knowing more about oral forms of insulin ,when it will be launched in India & wht will be the cost factor.

    Posted by dayananda salian |
  13. It is realy a facinating idea that in near future
    the old and tiresome procedure of pricking for gettin insuline will be an obsolete method and diabetic patients will take there required dose of insulin by mouth in the shape of tablet or capsules. I pray that such type of drug be soon awailable commercially in the market.

    Posted by Aftab Ahmed Baig |
  14. Thought everyone may find this of interest as Tamarisk is considering all license opportunities, giving every company large an small an opportunity to speak with us regarding oral insulin.

    You may wish to know Oral Insulin has been released and announced by Tamarisk Technologies, LLC. We are the first in the world to develope a transport vehicle allowing oral administration at therapeutic levels with an absolute bioavailability of an incredible 91.08% of administered insulin dose. Please see full in vivo study published by Tamarisk Technologies, LLC. This can be found at http://www.tamarisktechnologies.com. Plus some other major therapeutic peptides have been orally administered and studies there of published or in process thereof. Such as PYY 3-36, EPO, TNF, Herceptin and Pegylated Interferon.

    Kind Regards,

    Dr Daniel DeBrouse

    Posted by Dr Daniel Debrouse |
  15. Is this for real? Why isnt it in the news?


    Posted by Pharmahyde |
  16. Yes it most certainly is for real with a decade of scientific data to support. Both animal and human model testing. We are currently looking to the press to take it public shouldn’t be long. Keep in mind, however, this technology is disruptive to the industry and they have said as much so public demand may certainly be warranted.

    Posted by Dr Daniel Debrouse |
  17. Looks like the Tamarisk people moved sites…

    Does anyone know if they have been bought out?


    Posted by EscMatrix |

Post a Comment

Note: All comments are moderated and there may be a delay in the publication of your comment. Please be on-topic and appropriate. Do not disclose personal information. Be respectful of other posters. Only post information that is correct and true to your knowledge. When referencing information that is not based on personal experience, please provide links to your sources. All commenters are considered to be nonmedical professionals unless explicitly stated otherwise. Promotion of your own or someone else's business or competing site is not allowed: Sharing links to sites that are relevant to the topic at hand is permitted, but advertising is not. Once submitted, comments cannot be modified or deleted by their authors. Comments that don't follow the guidelines above may be deleted without warning. Such actions are at the sole discretion of DiabetesSelfManagement.com. Comments are moderated Monday through Friday by the editors of DiabetesSelfManagement.com. The moderators are employees of Madavor Media, LLC., and do not report any conflicts of interest. A privacy policy setting forth our policies regarding the collection, use, and disclosure of certain information relating to you and your use of this Web site can be found here. For more information, please read our Terms and Conditions.

Oral Medicines
Statins May Reduce Risk of Nerve Damage, Other Diabetes Complications (09/18/14)
New Metformin Combo Drug Approved for Type 2 Diabetes (08/13/14)
FDA Approves New Oral Drug for Type 2 Diabetes (08/07/14)
New SGLT Drugs Coming (07/23/14)

Insulin & Other Injected Drugs
New Weekly Type 2 Diabetes Drug Approved (09/26/14)
Dispelling the Myths of Insulin Therapy (08/01/14)
Insulin for Type 2 (07/14/14)
FDA Approves Inhalable Insulin (07/03/14)

Diabetes Research
Can Grapefruit Juice Prevent Weight Gain, Increase Insulin Sensitivity? (10/16/14)
Low-Carb Diet Improves Quality of Life in Type 2 Diabetes (10/07/14)
Long Hours at Low-Income Jobs Linked to Increased Diabetes Risk (10/02/14)
Statins May Reduce Risk of Nerve Damage, Other Diabetes Complications (09/18/14)

Diabetes News
FDA Approves Remote Glucose-Monitoring Technology (10/24/14)
Can Grapefruit Juice Prevent Weight Gain, Increase Insulin Sensitivity? (10/16/14)
Low-Carb Diet Improves Quality of Life in Type 2 Diabetes (10/07/14)
Long Hours at Low-Income Jobs Linked to Increased Diabetes Risk (10/02/14)



Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.